For Immediate Release, December 20, 2004

Media Availability:

Public Policy Expert on Canadian and U.S. Health Systems Responds to HHS Drug Importation Study

Sally Pipes, President and Chief Executive Officer of the Pacific Research Institute will be available to:

• Comment on the release of the HHS Importation Study and its conclusions
• Present the implications for the U.S. and Canadian health care systems
• Analyze the impact on international drug development and delivery

Background:
A Canadian residing in the U.S., Ms. Pipes writes, speaks, and presents invited testimony at the national and state levels on key health-care issues facing America. Topics have included the false promise of a single-payer system as it exists in Canada, pharmaceutical pricing, solving the problem of the uninsured, strategies for consumer-driven health care, and the importation of prescription drugs from Canada.

Ms. Pipes addresses national and international audiences on health care, women’s issues, education, privatization, civil rights, and the economy. She has been interviewed on CNNfn, “20/20,” “The Today Show,” “Dateline,” “Politically Incorrect,” “The Dennis Miller Show,” “Beyond the Beltway,” “The Week in Review,” and other prominent programs. She has written regular columns for Chief Executive, Investor’s Business Daily, and the San Francisco Examiner. Her opinion pieces have appeared in The Washington Post, Financial Times of London, Los Angeles Times, San Francisco Examiner, San Francisco Chronicle, Sacramento Bee, and Orange County Register.

###

About PRI
For more than two decades, the Pacific Research Institute for Public Policy (PRI) has championed individual liberty through free markets. PRI is a non-profit, non-partisan organization dedicated to promoting the principles of limited government, individual freedom, and personal responsibility.